Drug Co. Says Emory Prof Backing False Probiotic Claims

Law360 (May 24, 2021, 6:00 PM EDT) -- A probiotic seller has brought Lanham Act claims against a Georgia medical professor over his alleged continuing endorsement of a "poor imitation" product, after winning $18 million against the product makers in a separate case.

ExeGi Pharma LLC, based in Maryland, sued Roberto Pacifici, director of endocrinology at Emory University School of Medicine, in a Georgia federal court on Thursday, wanting at least $10 million in damages. ExeGi said business is being diverted away from its Visbiome probiotic by Pacifici's endorsement of knock-off product VSL#3, made by VSL Pharmaceuticals Inc.

ExeGi won $18 million at trial against VSL Pharmaceuticals and affiliates...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!